Unsatisfactory screening rates for Primary Aldosteronism in high risk patients
Preprint
- 13 February 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
The Endocrine Society (ES) guidelines recommend screening for primary aldosteronism (PA) in high risk hypertensive patients presenting with at least one of seven criteria (resistant HTN, hypokalemia, adrenal nodule etc.). Although guidelines are clear and screening is simple, compliance rates among clinicians are extremely low. This results in underdiagnosis of early disease, leading to cadiovasculaer complications and extra-burden of advanced chronic kidney disease. We aimed to evaluate the screening rates in the Nephrology and Hypertension clinics at Assuta Ashdod University Hospital, Israel. Data on adult hypertensive patients was retrieved during January 2018 to December 2020. Included in the study were hypertensive patients who had at least one of the ES criteria for PA screening. Of all suitable patients, we compared those who were screened for PA to patients who were not screened. Univariate and multivariate cox regression analysis were used for comparison between groups. Of 661 patients with HTN, 218 patients (33%) met the ES guidelines for PA screening. Forty-six of them (21.1%), were referred for screening. Advanced age and male gender were associated with lower screening referral rates. Odds ratio for age was 0.945 for every year (95% CI 0.915-0.975). There was a trend towards decreased referral rate in advanced kidney disease. A 21% screening rate, suggests that many cases of PA are likely missed, more often in older patients.We therefore advocate for PA screening of all hypertensive patients, especially elderly patients with CKD, in whom clinicians’ awareness is low but the absolute risk is high.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Personalized Treatment of Patients With Primary AldosteronismEndocrine Practice, 2022
- Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronismScientific Reports, 2021
- Resistant Hypertension in Chronic Kidney Disease (CKD): Prevalence, Treatment Particularities, and Research AgendaCurrent Hypertension Reports, 2020
- Age, Gender, and Body Mass Index as Determinants of Surgical Outcome in Primary AldosteronismHormone and Metabolic Research, 2020
- Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare systemSurgery, 2020
- Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensivesSurgery, 2019
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- A Late Diagnosis of Primary AldosteronismHigh Blood Pressure & Cardiovascular Prevention, 2017
- Potential effects of age on screening for primary aldosteronismJournal of Human Hypertension, 2015
- Primary aldosteronism: Rare bird or common cause of secondary hypertension?Current Hypertension Reports, 2001